Selective Wealth Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,880
Closed -$46K 324
2022
Q3
$46K Sell
1,880
-700
-27% -$19.4K 0.02% 308
2022
Q2
$69K Sell
2,580
-1,040
-29% -$33.4K 0.02% 268
2022
Q1
$142K Sell
3,620
-2,300
-39% -$89.2K 0.05% 168
2021
Q4
$271K Buy
5,920
+600
+11% +$28.6K 0.11% 94
2021
Q3
$252K Buy
5,320
+1,940
+57% +$90.6K 0.13% 83
2021
Q2
$157K Buy
+3,380
New +$153K 0.13% 86

Other funds holding FFTY

Selective Wealth Management's FFTY Position: Q4 2022 in Review

Selective Wealth Management sold out of CapForce IBD 50 ETF (FFTY) in Q4 2022, closing a stake of 1,880 shares — an estimated $46K sold.

Selective Wealth Management first reported a position in FFTY in Q2 2021 and held it in 6 quarters. The position peaked at $271K in Q4 2021. 49 funds tracked by Wall St. Rank hold FFTY as of Q4 2022.

  • Selective Wealth Management reported no remaining CapForce IBD 50 ETF position as of Q4 2022 after selling out during the quarter.
  • Selective Wealth Management sold 1,880 CapForce IBD 50 ETF shares in Q4 2022, an estimated $46K.
  • Selective Wealth Management first reported a position in CapForce IBD 50 ETF in Q2 2021 and held it in 6 quarters.
  • Selective Wealth Management's CapForce IBD 50 ETF position peaked at $271K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2022.

Based on Selective Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.